{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T07:41:40Z","timestamp":1769931700745,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund FWF","doi-asserted-by":"crossref","award":["P-32064"],"award-info":[{"award-number":["P-32064"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Health","award":["R01DK122813"],"award-info":[{"award-number":["R01DK122813"]}]},{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Posthepatectomy liver failure (PHLF) continues to be the most significant factor-determining outcome after hepatic resection, accounting for nearly half of postoperative mortality. In this study, we evaluated whether a newly developed commercially available test measuring circulating microRNAs (miRs) could predict PHLF and compared it with other established liver function tests.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>A total of 329 patients undergoing liver resection were included and postoperative outcome was assessed. Our previously described P-score, calculated on the basis of three circulating microRNAs (miR-122-5p, miR-192-5p, miR-151a-5p) using the hepatomiR<jats:sup>\u00ae<\/jats:sup> CE-IVD test, was evaluated and compared with other predictors of PHLF, namely indocyanine green (ICG)-clearance as well as the combined aspartate aminotransferase (AST)-to-platelet ratio index (APRI) and albumin\u2013bilirubin grade (ALBI) score.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Compared with both other liver function tests, P-scores were superior in predicting PHLF and PHLF grades B and C (PHLF B + C) (PHLF B + C: hepatomiR<jats:sup>\u00ae<\/jats:sup> AUC = 0.835, APRI + ALBI AUC = 0.807; retention rate at 15 min (R15) AUC = 0.690; plasma disappearance rate (PDR) AUC = 0.691). We also documented a superior positive (77%) and negative predictive value (&gt; 90%) for PHLF, along with a close association with postoperative overall survival. A health-economic analysis demonstrated the cost-effectiveness of hepatomiR<jats:sup>\u00ae<\/jats:sup> in terms of life-years gained due to improved patient risk stratification.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The hepatomiR<jats:sup>\u00ae<\/jats:sup> P-score outperforms established liver function tests utilized in daily clinical practice for predicting PHLF and identifies patients possibly better served with alternative treatments. A health-economic assessment allowed us to demonstrate that optimized preoperative risk-assessment leads to a cost-effective improvement in patient outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-025-17528-x","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T09:49:04Z","timestamp":1749116944000},"page":"6283-6294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MicroRNA based Prediction of Posthepatectomy Liver Failure and Mortality Outperforms Established Markers of Preoperative Risk Assessment"],"prefix":"10.1245","volume":"32","author":[{"given":"Anna Emilia","family":"Kern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pereyra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Santol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix Xaver","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremias","family":"Weninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Laferl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannic","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Jankoschek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Ortmayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Rumpf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Schuetze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosmarie","family":"Valenta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Krestan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guenther","family":"Zauner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Zechmeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Skalicky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Hackl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Assinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Gruenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Starlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"17528_CR1","doi-asserted-by":"publisher","unstructured":"Madoff DC, Odisio BC, Schadde E, et al. Improving the safety of major resection for hepatobiliary malignancy: portal vein embolization and recent innovations in liver regeneration strategies. Curr Oncol Rep. May 16 2020;22(6):59. https:\/\/doi.org\/10.1007\/s11912-020-00922-x","DOI":"10.1007\/s11912-020-00922-x"},{"issue":"5","key":"17528_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3978\/j.issn.2304-3881.2014.09.01","volume":"3","author":"R Kauffmann","year":"2014","unstructured":"Kauffmann R, Fong Y. Post-hepatectomy liver failure. Hepatobiliary Surg Nutr. 2014;3(5):238\u201346. https:\/\/doi.org\/10.3978\/j.issn.2304-3881.2014.09.01.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"6","key":"17528_CR3","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3906\/sag-2006-31","volume":"50","author":"\u0130 Ocak","year":"2020","unstructured":"Ocak \u0130, Topalo\u011flu S, Acarli K. Posthepatectomy liver failure. Turk J Med Sci. 2020;50(6):1491\u2013503. https:\/\/doi.org\/10.3906\/sag-2006-31.","journal-title":"Turk J Med Sci."},{"issue":"2","key":"17528_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejso.2020.09.001","volume":"47","author":"JA S\u00f8reide","year":"2021","unstructured":"S\u00f8reide JA, Deshpande R. Post hepatectomy liver failure (PHLF) - Recent advances in prevention and clinical management. Eur J Surg Oncol. 2021;47(2):216\u201324. https:\/\/doi.org\/10.1016\/j.ejso.2020.09.001.","journal-title":"Eur J Surg Oncol."},{"key":"17528_CR5","doi-asserted-by":"publisher","unstructured":"Sparrelid E, Olthof PB, Dasari BVM, et al. Current evidence on posthepatectomy liver failure: comprehensive review. BJS Open. Nov 2 2022;6(6)https:\/\/doi.org\/10.1093\/bjsopen\/zrac142","DOI":"10.1093\/bjsopen\/zrac142"},{"issue":"9","key":"17528_CR6","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/bjs.7630","volume":"98","author":"JS Hammond","year":"2011","unstructured":"Hammond JS, Guha IN, Beckingham IJ, Lobo DN. Prediction, prevention and management of postresection liver failure. Br J Surg. 2011;98(9):1188\u2013200. https:\/\/doi.org\/10.1002\/bjs.7630.","journal-title":"Br J Surg."},{"issue":"2","key":"17528_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/mcc.0000000000000291","volume":"22","author":"PA Kandiah","year":"2016","unstructured":"Kandiah PA, Olson JC, Subramanian RM. Emerging strategies for the treatment of patients with acute hepatic failure. Curr Opin Crit Care. 2016;22(2):142\u201351. https:\/\/doi.org\/10.1097\/mcc.0000000000000291.","journal-title":"Curr Opin Crit Care."},{"issue":"10","key":"17528_CR8","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/bjs\/znad233","volume":"110","author":"F Primavesi","year":"2023","unstructured":"Primavesi F, Maglione M, Cipriani F, et al. E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy. Br J Surg. 2023;110(10):1331\u201347. https:\/\/doi.org\/10.1093\/bjs\/znad233.","journal-title":"Br J Surg."},{"issue":"6","key":"17528_CR9","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1245\/s10434-010-1494-1","volume":"18","author":"PM Krieger","year":"2011","unstructured":"Krieger PM, Tamandl D, Herberger B, et al. Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing. Ann Surg Oncol. 2011;18(6):1644\u201350. https:\/\/doi.org\/10.1245\/s10434-010-1494-1.","journal-title":"Ann Surg Oncol."},{"key":"17528_CR10","doi-asserted-by":"publisher","unstructured":"Schwarz C, Plass I, Fitschek F, et al. The value of indocyanine green clearance assessment to predict postoperative liver dysfunction in patients undergoing liver resection. Sci Rep. Jun 10 2019;9(1):8421. https:\/\/doi.org\/10.1038\/s41598-019-44815-x","DOI":"10.1038\/s41598-019-44815-x"},{"key":"17528_CR11","doi-asserted-by":"publisher","unstructured":"Santol J, Kim S, Gregory LA, et al. An APRI+ALBI based multivariable model as preoperative predictor for posthepatectomy liver failure. Ann Surg. Oct 20 2023;https:\/\/doi.org\/10.1097\/sla.0000000000006127","DOI":"10.1097\/sla.0000000000006127"},{"issue":"2","key":"17528_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1055\/s-2008-1076681","volume":"25","author":"D Ribero","year":"2008","unstructured":"Ribero D, Chun YS, Vauthey JN. Standardized liver volumetry for portal vein embolization. Semin Intervent Radiol. 2008;25(2):104\u20139. https:\/\/doi.org\/10.1055\/s-2008-1076681.","journal-title":"Semin Intervent Radiol."},{"issue":"11","key":"17528_CR13","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.1007\/s00330-019-06101-2","volume":"29","author":"D Theilig","year":"2019","unstructured":"Theilig D, Steffen I, Malinowski M, et al. Predicting liver failure after extended right hepatectomy following right portal vein embolization with gadoxetic acid-enhanced MRI. Eur Radiol. 2019;29(11):5861\u201372. https:\/\/doi.org\/10.1007\/s00330-019-06101-2.","journal-title":"Eur Radiol."},{"issue":"3","key":"17528_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/01.sla.0000201482.11876.14","volume":"243","author":"M Nagino","year":"2006","unstructured":"Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243(3):364\u201372. https:\/\/doi.org\/10.1097\/01.sla.0000201482.11876.14.","journal-title":"Ann Surg."},{"issue":"6","key":"17528_CR15","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1002\/hep.30572","volume":"69","author":"P Starlinger","year":"2019","unstructured":"Starlinger P, Hackl H, Pereyra D, et al. Predicting postoperative liver dysfunction based on blood-derived microRNA signatures. Hepatology. 2019;69(6):2636\u201351. https:\/\/doi.org\/10.1002\/hep.30572.","journal-title":"Hepatology."},{"key":"17528_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2022.103170","volume":"40","author":"S Granieri","year":"2022","unstructured":"Granieri S, Bracchetti G, Kersik A, et al. Preoperative indocyanine green (ICG) clearance test: can we really trust it to predict post hepatectomy liver failure? A systematic review of the literature and meta-analysis of diagnostic test accuracy. Photodiagnosis Photodyn Ther. 2022;40:103170. https:\/\/doi.org\/10.1016\/j.pdpdt.2022.103170.","journal-title":"Photodiagnosis Photodyn Ther."},{"issue":"3","key":"17528_CR17","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1245\/s10434-018-07125-6","volume":"26","author":"D Pereyra","year":"2019","unstructured":"Pereyra D, Rumpf B, Ammann M, et al. The combination of APRI and ALBI facilitates preoperative risk stratification for patients undergoing liver surgery after neoadjuvant chemotherapy. Ann Surg Oncol. 2019;26(3):791\u20139. https:\/\/doi.org\/10.1245\/s10434-018-07125-6.","journal-title":"Ann Surg Oncol."},{"key":"17528_CR18","doi-asserted-by":"publisher","unstructured":"Baumgartner R, Gilg S, Bj\u00f6rnsson B, et al. Impact of post-hepatectomy liver failure on morbidity and short- and long-term survival after major hepatectomy. BJS Open. Jul 7 2022;6(4)https:\/\/doi.org\/10.1093\/bjsopen\/zrac097","DOI":"10.1093\/bjsopen\/zrac097"},{"issue":"10\u201311","key":"17528_CR19","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1080\/00365521.2018.1501604","volume":"53","author":"S Gilg","year":"2018","unstructured":"Gilg S, Sandstr\u00f6m P, Rizell M, et al. The impact of post-hepatectomy liver failure on mortality: a population-based study. Scand J Gastroenterol Oct-Nov. 2018;53(10\u201311):1335\u20139. https:\/\/doi.org\/10.1080\/00365521.2018.1501604.","journal-title":"Scand J Gastroenterol. Oct-Nov"},{"issue":"4","key":"17528_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11605-013-2423-y","volume":"18","author":"K Fukushima","year":"2014","unstructured":"Fukushima K, Fukumoto T, Kuramitsu K, et al. Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma. J Gastrointest Surg. 2014;18(4):729\u201336. https:\/\/doi.org\/10.1007\/s11605-013-2423-y.","journal-title":"J Gastrointest Surg."},{"issue":"3","key":"17528_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.hpb.2018.07.019","volume":"21","author":"K Joechle","year":"2019","unstructured":"Joechle K, Goumard C, Vega EA, et al. Long-term survival after post-hepatectomy liver failure for colorectal liver metastases. HPB (Oxford). 2019;21(3):361\u20139. https:\/\/doi.org\/10.1016\/j.hpb.2018.07.019.","journal-title":"HPB (Oxford)."},{"key":"17528_CR22","doi-asserted-by":"publisher","unstructured":"Lee JW, Lee JH. Risk factors of hepatic failure after liver resection for perihilar cholangiocarcinoma: Importance of future liver remnant volume, body weight ratio, and impact on long-term survival. J Clin Oncol. 2019;37(4_suppl):348-348. https:\/\/doi.org\/10.1200\/JCO.2019.37.4_suppl.348","DOI":"10.1200\/JCO.2019.37.4_suppl.348"},{"issue":"6","key":"17528_CR23","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jhep.2011.11.026","volume":"56","author":"F Borel","year":"2012","unstructured":"Borel F, Konstantinova P, Jansen PL. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J Hepatol. 2012;56(6):1371\u201383. https:\/\/doi.org\/10.1016\/j.jhep.2011.11.026.","journal-title":"J Hepatol."},{"key":"17528_CR24","doi-asserted-by":"publisher","unstructured":"Masuda T, Hayashi N, Kuroda Y, Ito S, Eguchi H, Mimori K. MicroRNAs as biomarkers in colorectal cancer. Cancers (Basel). Sep 13 2017;9(9)https:\/\/doi.org\/10.3390\/cancers9090124","DOI":"10.3390\/cancers9090124"},{"issue":"7","key":"17528_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrg3965","volume":"16","author":"S Jonas","year":"2015","unstructured":"Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. 2015;16(7):421\u201333. https:\/\/doi.org\/10.1038\/nrg3965.","journal-title":"Nat Rev Genet."},{"issue":"2","key":"17528_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s1499-3872(15)60036-4","volume":"15","author":"PS Yi","year":"2016","unstructured":"Yi PS, Zhang M, Xu MQ. Role of microRNA in liver regeneration. Hepatobiliary Pancreat Dis Int. 2016;15(2):141\u20136. https:\/\/doi.org\/10.1016\/s1499-3872(15)60036-4.","journal-title":"Hepatobiliary Pancreat Dis Int."},{"issue":"5","key":"17528_CR27","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451\u201365. https:\/\/doi.org\/10.1002\/jcp.27486.","journal-title":"J Cell Physiol."},{"issue":"1","key":"17528_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0034-1397344","volume":"35","author":"AM Mohr","year":"2015","unstructured":"Mohr AM, Mott JL. Overview of microRNA biology. Semin Liver Dis. 2015;35(1):3\u201311. https:\/\/doi.org\/10.1055\/s-0034-1397344.","journal-title":"Semin Liver Dis."},{"issue":"2","key":"17528_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","volume":"62","author":"S Bandiera","year":"2015","unstructured":"Bandiera S, Pfeffer S, Baumert TF, Zeisel MB. miR-122\u2013a key factor and therapeutic target in liver disease. J Hepatol. 2015;62(2):448\u201357. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.004.","journal-title":"J Hepatol."},{"issue":"46","key":"17528_CR30","doi-asserted-by":"publisher","first-page":"32015","DOI":"10.1074\/jbc.M109.016774","volume":"284","author":"S Bai","year":"2009","unstructured":"Bai S, Nasser MW, Wang B, et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem. 2009;284(46):32015\u201327. https:\/\/doi.org\/10.1074\/jbc.M109.016774.","journal-title":"J Biol Chem."},{"issue":"4","key":"17528_CR31","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","volume":"70","author":"X Wang","year":"2021","unstructured":"Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut. 2021;70(4):784\u201395. https:\/\/doi.org\/10.1136\/gutjnl-2020-322526.","journal-title":"Gut."},{"key":"17528_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114862","volume":"195","author":"YM Chang","year":"2022","unstructured":"Chang YM, Chen PC, Hsu CP, Ma PF, Chen HL, Hsu SH. Loss of hepatic miR-194 promotes liver regeneration and protects from acetaminophen-induced acute liver injury. Biochem Pharmacol. 2022;195:114862. https:\/\/doi.org\/10.1016\/j.bcp.2021.114862.","journal-title":"Biochem Pharmacol."},{"key":"17528_CR33","doi-asserted-by":"publisher","unstructured":"Ding J, Huang S, Wu S, et al. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol. Apr 2010;12(4):390-9. https:\/\/doi.org\/10.1038\/ncb2039","DOI":"10.1038\/ncb2039"},{"issue":"3","key":"17528_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s12072-018-9871-0","volume":"12","author":"JL Cheng","year":"2018","unstructured":"Cheng JL, Zhao H, Yang SG, Chen EM, Chen WQ, Li LJ. Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALT. Hepatol Int. 2018;12(3):277\u201387. https:\/\/doi.org\/10.1007\/s12072-018-9871-0.","journal-title":"Hepatol Int."},{"key":"17528_CR35","doi-asserted-by":"publisher","unstructured":"Starlinger P, Ubl DS, Hackl H, et al. Combined APRI\/ALBI score to predict mortality after hepatic resection. BJS Open. Jan 8 2021;5(1)https:\/\/doi.org\/10.1093\/bjsopen\/zraa043","DOI":"10.1093\/bjsopen\/zraa043"},{"issue":"4","key":"17528_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/1457496916683094","volume":"106","author":"S Amptoulach","year":"2017","unstructured":"Amptoulach S, Gross G, Sturesson C, Rissler P, Kalaitzakis E. Preoperative aspartate aminotransferase-to-platelet ratio index predicts perioperative liver-related complications following liver resection for colorectal cancer metastases. Scand J Surg. 2017;106(4):311\u20137. https:\/\/doi.org\/10.1177\/1457496916683094.","journal-title":"Scand J Surg."},{"issue":"48","key":"17528_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000005486","volume":"95","author":"J Cheng","year":"2016","unstructured":"Cheng J, Zhao P, Liu J, Liu X, Wu X. Preoperative aspartate aminotransferase-to-platelet ratio index (APRI) is a predictor on postoperative outcomes of hepatocellular carcinoma. Medicine (Baltimore). 2016;95(48):e5486. https:\/\/doi.org\/10.1097\/md.0000000000005486.","journal-title":"Medicine (Baltimore)."},{"issue":"5","key":"17528_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100347","volume":"3","author":"CO Demirtas","year":"2021","unstructured":"Demirtas CO, D\u2019Alessio A, Rimassa L, Sharma R, Pinato DJ. ALBI grade: evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma. JHEP Rep. 2021;3(5):100347. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100347.","journal-title":"JHEP Rep."},{"issue":"1 Suppl","key":"17528_CR39","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/j.jhep.2015.02.007","volume":"62","author":"J Bruix","year":"2015","unstructured":"Bruix J, Han KH, Gores G, Llovet JM, Mazzaferro V. Liver cancer: approaching a personalized care. J Hepatol. 2015;62(1 Suppl):S144\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.007.","journal-title":"J Hepatol."},{"issue":"2","key":"17528_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.canlet.2015.07.018","volume":"379","author":"L Li","year":"2016","unstructured":"Li L, Wang H. Heterogeneity of liver cancer and personalized therapy. Cancer Lett. 2016;379(2):191\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2015.07.018.","journal-title":"Cancer Lett."},{"key":"17528_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.omtm.2021.12.007","volume":"24","author":"D de Gonzalo-Calvo","year":"2022","unstructured":"de Gonzalo-Calvo D, Marchese M, Hellemans J, et al. Consensus guidelines for the validation of qRT-PCR assays in clinical research by the CardioRNA consortium. Mol Ther Methods Clin Dev. 2022;24:171\u201380. https:\/\/doi.org\/10.1016\/j.omtm.2021.12.007.","journal-title":"Mol Ther Methods Clin Dev."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17528-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17528-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17528-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:02:15Z","timestamp":1754150535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17528-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["17528"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17528-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patrick Starlinger was involved in the development of hepatomiR\u00ae, the testing system discussed in this article and is a consultant for TAmiRNA GmbH, the company that developed hepatomiR\u00ae. Alice Assinger was involved in the development of hepatomiR\u00ae. Matthias Hackl is employed by and owns stock in TAmiRNA GmbH. Susanna Skalicky is employed by TAmiRNA GmbH.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}